Drug
Leo 142397
Leo 142397: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 142397 NCT03995550 | Phase 1 |
Latest
No recent events.
Follow Leo 142397 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.